drugset
drugset / Trial / NCT04616742

Study to Evaluate the Mass Babance and Biotransformation of [14C]SHR6390 in Healthy Adult Male Volunteers

NCT04616742 ↗

Phase 1 Completed 6 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelOther

Summary

Study to Evaluate the mass balance and biotransformation of single dose \[14C\]SHR6390 in Chinese healthy adult male volunteers.

Timeline

Start
2020-11-11
Primary completion
2021-01-08
Completion
2021-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dalpiciclib Small molecule — Oral

Indications

No indication recorded.